表紙
市場調査レポート

婦人科医療機器の世界市場

Global Gynecological Devices Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 307318
出版日 ページ情報 英文 96 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
婦人科医療機器の世界市場 Global Gynecological Devices Market 2014-2018
出版日: 2014年06月30日 ページ情報: 英文 96 Pages
概要

婦人科医療機器は、女性の生殖器官や受胎能力に影響を与えるさまざまな婦人科疾病、また月経過多、感染症、子宮内膜症、妊娠糖尿病、多嚢胞性卵巣症候群、子宮筋腫、骨盤底機能障害などの疾患に対して医療処置を施すために使用されます。この世界市場は2014年から2018年までの期間、6.63%の年平均成長率(CAGR)で成長を続けるものと予測されます。

当レポートは世界の婦人科医療機器市場を精査しており、現況分析とともに、市場の成長促進要因と課題、市場動向、また市場競争状況を詳細に分析し、今後の成長見通しおよび市場予測を提供しています。地域別分析としては市場をアジア太平洋地域、欧州・中東・アフリカ地域、および南北アメリカ地域に分類し、それぞれ市場規模の算定ならびに将来市場の予測を行っています。

第1章 エグゼクティブ・サマリー

第2章 略語一覧

第3章 当レポートの調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 序論

第6章 市場概況

  • 市場概要
  • 市場規模および将来予測
  • ファイブフォース分析

第7章 用途別市場分類

第8章 地域別市場分析

第9章 購入基準

第10章 市場成長促進要因

第11章 市場成長促進要因とその影響

第12章 市場の課題

第13章 市場成長促進要因と課題とが及ぼす影響

第14章 市場動向

第15章 市場動向とそれによる影響

第16章 ベンダー状況

  • 市場競争シナリオ
    • 重要なニュース
    • 企業吸収合併
  • 市場シェア分析: 2013年
  • その他の有力企業

第17章 主要ベンダー分析

  • Bayer AG
    • 主要データ
    • ビジネス概要
    • ビジネス分類
    • ビジネス戦略
    • ビジネス別売り上げ内訳
    • 地域別売り上げ内訳
    • 重要情報
    • SWOT分析
  • Boston Scientific Corp.
  • CooperSurgical Inc.
  • Ethicon Inc.
  • Hologic Inc.
  • Medtronic Inc.
  • オリンパス株式会社

第18章 関連レポート

目次
Product Code: IRTNTR3702

About Gynecological Devices

Gynecological devices have been broadly classified into wide categories based on their operations. These devices are used for the treatment of different gynecological conditions that affect the female reproduction organs, female fertility, menorrhagia (heavy menstrual periods), infections, and disorders such as endometriosis, gestational diabetes, polycystic ovary syndrome, uterine fibroids, and pelvic floor disorders. Every woman faces a gynecological condition at some point in her life. Several conditions may be easily treatable and several may be life threatening. The gynecological devices help by having an impact on a woman's infertility , treat serious illnesses, and treat the devastating consequences that are life threatening. The gynecological devices are made to perform with advanced technologies and procedures to improve the treatment of complex gynecology surgeries. Several devices are portable, disposable, and very easy to handle and can be used in any gynecology centers.

TechNavio's analysts forecast the Global Gynecological Devices market will grow at a CAGR of 6.63 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Gynecological Devices market for the period 2014-2018. The Global Gynecological Devices market can be segmented into four divisions: Gynecologic Surgical Devices, Diagnostic Imaging Systems, Gynecological Chairs, and Hand Instruments. These are sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.

TechNavio's report, the Global Gynecological Devices Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gynecological Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Bayer AG
  • Boston Scientific Corp.
  • CooperSurgical Inc.
  • Ethicon Inc.
  • Hologic Inc.
  • Medtronic Inc.
  • Olympus Corp.
  • Stryker Corp.

Other Prominent Vendors

  • ATMOS MedizinTechnik GmbH & Co. KG
  • BTL Medical technologies Inc.
  • KARL STORZ GmbH & Co. KG
  • Meditelle Medical Equipment Ltd.
  • Richard Wolf GmbH
  • Welch Allyn, Inc.

Key Market Driver

  • Increase in the Prevalence of Gynecological Conditions

For a full, detailed list, view our report

Key Market Challenge

  • Increase in Use of CAM and Drugs

For a full, detailed list, view our report

Key Market Trend

  • Ongoing Technological Innovation

For a full, detailed list, view our report

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Bayer AG
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation
    • 17.1.4. Business Strategy
    • 17.1.5. Sales Segmentation by Business
    • 17.1.6. Sales by Geographical Segmentation
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
    • 17.1.9. Strengths
    • 17.1.10. Weaknesses
    • 17.1.11. Opportunities
    • 17.1.12. Threats
  • 17.2. Boston Scientific Corp.
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation
    • 17.2.4. Business Strategy
    • 17.2.5. Revenue Segmentation by Business
    • 17.2.6. Revenue Comparison 2012 and 2013
    • 17.2.7. Sales by Geography
    • 17.2.8. Key Developments
    • 17.2.9. SWOT Analysis
    • 17.2.10. Strengths
    • 17.2.11. Weaknesses
    • 17.2.12. Opportunities
    • 17.2.13. Threats
  • 17.3. CooperSurgical Inc.
    • 17.3.1. Key Facts
    • 17.3.2. Business Description
    • 17.3.3. Business Segmentation
    • 17.3.4. Business Segmentation by Revenue
    • 17.3.5. Business Segmentation by Revenue 2012 and 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Key Developments
    • 17.3.8. SWOT Analysis
    • 17.3.9. Strengths
    • 17.3.10. Weaknesses
    • 17.3.11. Opportunities
    • 17.3.12. Threats
  • 17.4. Ethicon Inc.
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Business Strategy
    • 17.4.5. Key Information
    • 17.4.6. SWOT Analysis
    • 17.4.7. Strengths
    • 17.4.8. Weaknesses
    • 17.4.9. Opportunities
    • 17.4.10. Threats
  • 17.5. Hologic Inc.
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Sales by Geography
    • 17.5.6. Business Strategy
    • 17.5.7. Key Developments
    • 17.5.8. SWOT Analysis
    • 17.5.9. Strengths
    • 17.5.10. Weaknesses
    • 17.5.11. Opportunities
    • 17.5.12. Threats
  • 17.6. Medtronic Inc.
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation
    • 17.6.4. Revenue by Business Segmentation
    • 17.6.5. Revenue Comparison 2012 and 2013
    • 17.6.6. Revenue Segmentation by Geography
    • 17.6.7. Business Strategy
    • 17.6.8. Key Developments
    • 17.6.9. SWOT Analysis
    • 17.6.10. Strengths
    • 17.6.11. Weaknesses
    • 17.6.12. Opportunities
    • 17.6.13. Threats
  • 17.7. Olympus Corp.
    • 17.7.1. Key Facts
    • 17.7.2. Business Overview
    • 17.7.3. Business Segmentation by Revenue 2013
    • 17.7.4. Sales by Geography
    • 17.7.5. Business Strategy
    • 17.7.6. Key Information
    • 17.7.7. SWOT Analysis
    • 17.7.8. Strengths
    • 17.7.9. Weaknesses
    • 17.7.10. Opportunities
    • 17.7.11. Threats

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Gynecological Devices Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Gynecology Devices Market Segmentation by Application
  • Exhibit 4: Global Gynecological Devices market by Geographical Segmentation 2013
  • Exhibit 5: Business Segmentation of Bayer AG 2013
  • Exhibit 6: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
  • Exhibit 7: Sales Segmentation of Bayer AG by Geography 2013
  • Exhibit 8: Boston Scientific Corp.: Business Segmentation 2013
  • Exhibit 9: Boston Scientific Corp.: Revenue Segmentation by Business2013
  • Exhibit 10: Boston Scientific Corp.: Revenue Comparison 2012 and 2013 (US$ billion)
  • Exhibit 11: Boston Scientific Corp.: Sales by Geography 2013
  • Exhibit 12: CooperSurgical Inc.: Business Segmentation 2013
  • Exhibit 13: CooperSurgical Inc.: Business Segmentation by Revenue 2013
  • Exhibit 14: CooperSurgical Inc.: Business Segmentation by Revenue 2012 and 2013(US$ million)
  • Exhibit 15: Ethicon Inc.: Business Segmentation 2013
  • Exhibit 16: Revenue Segmentation of Hologic Inc. 2013
  • Exhibit 17: Revenue Comparison FY2012 and FY2013 (US$ million)
  • Exhibit 18: Hologic Inc.: Sales by Geography 2013
  • Exhibit 19: Exhibit 1: Medtronic Inc.: Business Segmentation
  • Exhibit 20: Exhibit 2: Medtronic Inc.: Revenue by Business Segmentation 2013
  • Exhibit 21: Exhibit 3: Medtronic Inc.: Revenue Comparison 2012 and 2013 (US$ million)
  • Exhibit 22: Exhibit 4: Medtronic Inc.: Revenue Segmentation by Geography 2013
  • Exhibit 23: Olympus Corp.: Business Segmentation 2013 by Revenue 2013
  • Exhibit 24: Olympus Corp.: Sales by Geography 2013
Back to Top